Musaffa Logo
Axonics Inc AXNX

Last Updated: Nov 14, 12:00 AM·XDUS

AXNX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Axonics Inc is classified as halal.

HALAL

Report Source: 2024 3rd Quarter Report

Axonics Inc

Axonics Inc. Stock Analysis AXNX

Germany Health Care Mid Cap Report:
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. The company is headquartered in Irvine, California and currently employs 797 full-time employees. The company went IPO on 2018-10-31. The firm has designed and developed both rechargeable (R20) and recharge-free (F15) implantable sacral neuromodulation (SNM) systems, which deliver mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder (OAB), urinary retention (UR) and fecal incontinence (FI). The recharge-free implantable neurostimulator (INS) is approximately 10cc in volume, utilizes constant current stimulation, an easy-to-use, intuitive recharge-free patient remote control and other related accessories. The company engineered its recharge-free sacral neuromodulation (SNM) system to deliver constant-current stimulation. Its SNM system includes an easy-to-use wireless patient remote control that does not require recharging or replacement batteries.
Read More

Axonics Inc (AXNX) Chart

Key Statistics of Axonics Inc (AXNX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$70.37$71.05

Today's Open

$70.50

Volume

4.23M

P/E Ratio (TTM)

-

52 Week Range

$47.61$71.97

Market Cap

3.63B

Avg. Volume

554.59K

Dividend Yield

-

Financial Metrics & Statements of Axonics Inc (AXNX)

Super Investors Invested in Axonics Inc (AXNX)

FAQ's for Axonics Inc (AXNX)

  • As of July 2026, Axonics Inc AXNX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Axonics Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Axonics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Axonics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Axonics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Axonics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.